{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00540150",
      "orgStudyIdInfo": {
        "id": "97/04/FFM"
      },
      "organization": {
        "fullName": "Johann Wolfgang Goethe University Hospital",
        "class": "OTHER"
      },
      "briefTitle": "Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy",
      "officialTitle": "Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy in a Randomized Study Depending on Mite-Depot Supplement in Children and Adolescents With Allergic Bronchial Asthma."
    },
    "statusModule": {
      "statusVerifiedDate": "2007-09",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2004-05"
      },
      "completionDateStruct": {
        "date": "2005-03",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2007-10-02",
      "studyFirstSubmitQcDate": "2007-10-04",
      "studyFirstPostDateStruct": {
        "date": "2007-10-05",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2007-10-04",
      "lastUpdatePostDateStruct": {
        "date": "2007-10-05",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "leadSponsor": {
        "name": "Johann Wolfgang Goethe University Hospital",
        "class": "OTHER"
      },
      "collaborators": [
        {
          "name": "Allergopharma GmbH & Co. KG",
          "class": "INDUSTRY"
        }
      ]
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy.\n\nTherefore, we challenged 12 patients for 14 weeks with the standard specific scheme and 22 patients for 6 weeks with the shortened scheme.",
      "detailedDescription": "see above"
    },
    "conditionsModule": {
      "conditions": [
        "Immunotherapy"
      ],
      "keywords": [
        "Immunotherapy",
        "Mite",
        "Asthma",
        "bronchial provocation",
        "SIT",
        "specific immunotherapy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 34,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "1",
          "type": "ACTIVE_COMPARATOR",
          "description": "Standard specific immunotherapy: Novo-Helisen Depot, Allergopharma Inc., Reinbek, Germany",
          "interventionNames": [
            "Biological: specific subcutaneous immunotherapy house dust mite allergoid (Novo-Helisen Depot)"
          ]
        },
        {
          "label": "2",
          "type": "ACTIVE_COMPARATOR",
          "description": "Shortened specific immunotherapy: Novo-Helisen Depot, Allergopharma Inc., Reinbek, Germany",
          "interventionNames": [
            "Biological: specific subcutaneous immunotherapy house dust mite allergoid (Novo-Helisen Depot)"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "specific subcutaneous immunotherapy house dust mite allergoid (Novo-Helisen Depot)",
          "description": "We treat each patient with mite-allergen following the two different protocols.",
          "armGroupLabels": [
            "1",
            "2"
          ],
          "otherNames": [
            "Novo-Helisen Depot, Allergopharma Inc., Reinbek, Germany"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Safety of the shortened specific immunotherapy.",
          "timeFrame": "may 2004 - march 2005"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Exhaled nitric oxid (eNO) and immunogenicity (IgE, specific IgE, specific IgG) in both groups.",
          "timeFrame": "may 2004 - march 2005"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* informed consent of patient and/or parents\n* age \\>6 and \\<18 years\n* bronchial asthma I째 or II째\n* allergy on house dust-mite\n\nExclusion Criteria:\n\n* age \\<6 and \\>18 years\n* vital capacity \\<80% or FEV1 \\<70%\n* pregnancy\n* inhalative or systemic steroid use\n* bronchial asthma III째 or IV째\n* heavy exacerbation during the last 3 months",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "6 Years",
      "maximumAge": "18 Years",
      "stdAges": [
        "CHILD",
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Stefan Zielen, M.D., Ph.D.",
          "affiliation": "Goethe University, Department of Pulmonology",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Goethe University, Department of Pulmonology",
          "city": "Frankfurt am Main",
          "state": "Hesse",
          "zip": "60590",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.11552,
            "lon": 8.68417
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "12915987",
          "type": "BACKGROUND",
          "citation": "Hansen I, Hormann K, Stuck BA, Schneider-Gene S, Mosges R, Klimek L. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)]. Laryngorhinootologie. 2003 Aug;82(8):558-63. doi: 10.1055/s-2003-41234. German."
        },
        {
          "pmid": "15990782",
          "type": "BACKGROUND",
          "citation": "Tabar AI, Echechipia S, Garcia BE, Olaguibel JM, Lizaso MT, Gomez B, Aldunate MT, Martin S, Marcotegui F. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol. 2005 Jul;116(1):109-18. doi: 10.1016/j.jaci.2005.05.005."
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D001249",
          "term": "Asthma"
        }
      ],
      "ancestors": [
        {
          "id": "D001982",
          "term": "Bronchial Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D008173",
          "term": "Lung Diseases, Obstructive"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "C014135",
          "term": "Novo-Helisen Depot"
        }
      ]
    }
  },
  "hasResults": false
}